PA
CYD icon

PharVision Advisers’s China Yuchai International CYD Stock Holding History

PharVision Advisers’s Portfolio CYD Stock Details CYD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,807
Closed -$277K – 244
2025
Q4 		$277K Buy
+7,807
New +$285K 0.14% 323

Other funds holding CYD

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $100M AUM 90.57% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PharVision Advisers's CYD Position: Q1 2026 in Review

PharVision Advisers sold out of China Yuchai International (CYD) in Q1 2026, closing a stake of 7,807 shares — an estimated $277K sold.

PharVision Advisers first reported a position in CYD in Q4 2025 and held it in 1 quarter. The position peaked at $277K in Q4 2025. 108 funds tracked by Wall St. Rank hold CYD as of Q1 2026.

  • PharVision Advisers reported no remaining China Yuchai International position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 7,807 China Yuchai International shares in Q1 2026, an estimated $277K.
  • PharVision Advisers first reported a position in China Yuchai International in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's China Yuchai International position peaked at $277K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held China Yuchai International as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.